Lucie Heinzerling Patrick A Ott F Stephen Hodi Aliya N Husain Azadeh Tajmir-Riahi Hussein Tawbi Matthias Pauschinger Thomas F Gajewski Evan J Lipson Jason J Luke
10.1186/s40425-016-0152-y
J Immunother Cancer
2016 Aug 16;4:50.
cardiomyopathy checkpoint inhibitor immune-related adverse events immunotherapy ipilimumab melanoma myocarditis nivolumab pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/27532025/
PMC4986340
27532025
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
2016